Reteplase ( rPA ) for Injection
[Dosage Form] Freeze-dried powder for injection.
[Indications]
Indicated for use in the management of acute myocardial infarction in adults for the improvement of ventricular function following AMI .
[Highlights]
Retaplase is the third generation thrombolytic drug, compared with Activase (Alteplase) from Boehringer Ingelheim GmbH, the second generation thrombolytic drug
Retaplase has the advantages below:
• More convenient administration
• Less dosage
• Less adverse reaction
智藥研習(xí)社官方微信
制藥在線官方微信
2006-2025 上海博華國(guó)際展覽有限公司版權(quán)所有(保留一切權(quán)利)
滬ICP備05034851號(hào)-57